Aoyuan Beauty Valley Technology Co.Ltd(000615)
Financial statement report of 2021 and budget report of 2022
1、 Financial accounts of 2021
1. Financial statements and audit of the company in 2021
(1) Accounting system for financial reporting: the company implements the relevant provisions of the accounting standards for business enterprises and Its Application guide.
(2) Audit of financial statements: the financial statements of the company in 2021 have been audited by Zhongshen Zhonghuan Certified Public Accountants (special general partnership), and an audit report with standard unqualified opinions with emphasized items has been issued.
2. Specific contents of financial final accounts in 2021
(1) Consolidated and financial position of the company as of December 31, 2021
At the end of 2021, the total assets of the company were 4321165800 yuan, a decrease of 5132008200 yuan or 54.29% compared with 9453174000 yuan at the beginning of the year. At the end of 2021, the total liabilities of the company were 2394125100 yuan, a decrease of 4406169400 yuan or 64.79% compared with 68 Chinalin Securities Co.Ltd(002945) 00 yuan at the beginning of the year. At the end of 2021, the owner’s equity attributable to the shareholders of the parent company was 1465748900 yuan, including 7811803 million yuan of share capital, 1089897 million yuan of treasury shares, 8.9669 million yuan of surplus reserve, 36.958 million yuan of other comprehensive income and 7476334 million yuan of undistributed profit.
Unit: 10000 yuan
Proportion of project amount to total assets proportion of project amount to total assets
Monetary capital 6044904 13.99% interest bearing liabilities 2643730 6.12% (within one year)
Other current assets 4850007 11.22% interest bearing liabilities 11379041 26.33% (more than one year)
Total current assets 10894911 25.21% other liabilities 9918481 22.95%
Self owned and investment properties 23825894 55.14% total liabilities 23941251 55.40%
Other assets 8490853 19.65% belong to listed companies 14657489 33.92% of net assets
Total non current assets 32316747 74.79% minority shareholders’ equity 4612918 10.68%
Total assets 43211658 100.00% liabilities and shareholders’ equity 43211658 100.00% benefits
(2) Operating results and cash flows of the merger and the company in 2021
Increase or decrease of current period amount (10000 yuan) and previous period amount (10000 yuan)
Operating income 1538671119873441 – 22.58%
Total profit -22488541330516 -269.02%
Net profit -2694035381707 -805.79%
Net profit attributable to owners of parent company -2533723 -1347494 -88.03%
The net increase in cash and cash equivalents was 149931300 yuan, including:
① The cash inflow from operating activities is 25683875 million yuan, the cash outflow is 26826452 million yuan, and the net cash flow from operating activities is 1142576 million yuan;
② The cash inflow from investment activities is 119387500 yuan, the cash outflow is 1207570700 yuan, and the net cash flow from investment activities is 13693200 yuan;
③ The cash inflow from financing activities is 1754352400 yuan, the cash outflow is 1459276500 yuan, and the net cash flow from financing activities is 295075900 yuan.
(3) Main financial indicators
Return on net assets and earnings per share
Change range of the project in the same period of last year in the reporting period
Basic earnings per share (yuan) -0.32 -0.17 -15.00%
Weighted average return on net assets – 15.55% – 7.59% – 7.96%
Increase or decrease of the project at the end of the reporting period and at the beginning of the reporting period
Owner’s equity attributable to shareholders of listed companies (10000 yuan) 1485477417138882 – 13.33%
Net assets per share attributable to shareholders of listed companies (yuan) 1.90 2.19 – 13.24%
The total capital stock at the end of the period and at the beginning of the report are 780300 shares.
Other financial indicators
Increase and decrease of the project in the same period of last year in the reporting period
Gross profit margin 21.47% – 27.01% – 20.51% profitability index
Net profit margin on sales – 17.51% – 1.92% – 101159%
Solvency Index current ratio 76.65%, 61.47%, 24.71%, asset liability ratio 55.40%, 71.94% – 22.98%
Cash flow indicators net cash flow from operating activities per share -0.15 -0.49 -70.14%
3. Investment situation
During the reporting period, the company signed an equity transfer agreement with Shenzhen Kaixian Investment Co., Ltd. to sell its 100% equity of Jinghan Real Estate Group Co., Ltd., 100% equity of Beijing Yangjia Health Management Co., Ltd. and 35% equity of Penglai Hualu Jinghan Elderly Care Service Co., Ltd., with a transfer amount of 102 million yuan.
During the reporting period, the company acquired 55% equity of “Zhejiang liantianmei Enterprise Management Co., Ltd.” from its holding subsidiary Guangzhou Ogilvy Industrial Investment Co., Ltd., with an equity consideration of 696666700 yuan; Guangzhou Allmed Medical Products Co.Ltd(002950) beauty Investment Co., Ltd., an indirect holding subsidiary, acquired 100% equity of “Guangdong Aurora Health Management Consulting Co., Ltd.” with an equity consideration of 30 million yuan.
2、 Financial budget for 2022
1. Budget preparation description
This budget report is prepared by the company on the principle of prudence, in combination with market demand and business development plan, according to the production scale, sales volume, store passenger flow, saleable product models and other production or procurement business plans and sales prices in the 2022 budget. The preparation basis of this budget report is: it is assumed that the supply and marketing contracts signed by the company can be performed on time and as planned.
On the basis of summarizing the business situation in 2021 and analyzing the business situation in 2022, combined with the company’s development strategy, this budget report fully considers the impact of market development, product sales price, raw material price, chemical fiber, medical and beauty market and exchange rate on the budget period.
2. Basic assumptions
(1) There is no significant change in the current relevant national and local laws, regulations and systems followed by the company; (2) There is no significant change in the socio-economic environment of the company’s main business location and business areas;
(3) There is no significant change in the industry situation and market situation of the company;
(4) There is no significant change in the market involved in the products sold by the company in 2022;
(5) The market price and supply-demand relationship of the company’s main products and raw materials will not change significantly;
(6) The production and operation of the company in 2022 will not be adversely affected by the serious shortage of transportation, hydropower and raw materials and the huge changes of objective factors in cost;
(7) The credit interest rate, tax policy and foreign exchange market exchange rate involved in the production and operation of the company will fluctuate within the normal range;
(8) There is no significant change in the current production organization structure of the company, and the planned investment projects can be completed and put into production on schedule;
(9) There is no significant adverse impact on the company caused by other force majeure and unforeseen factors.
3. Budgeting basis
The company’s main product sales target in 2022: the company expects to achieve an operating revenue of 1.2-1.6 billion yuan in 2022.
Budget basis: the operating revenue is based on the 2022 product sales plan predicted by the company’s sales department; The operating cost is calculated according to the raw material consumption and manufacturing expenses of the company’s products; Business taxes and surcharges, sales expenses, administrative expenses and financial expenses are calculated according to the actual expenses of the company in 2021 and the increase and decrease of expenses are properly considered; According to the enterprise income tax law, the enterprise income tax is budgeted at the tax rate of 25% for medical beauty business and other businesses, and 15% for chemical fiber business.
4. Measures to ensure the completion of financial budget
(1) Strengthen R & D, production and sales, operate scientifically and achieve business objectives;
(2) Continue to implement comprehensive budget management and establish and improve the cost control system and system of all staff;
(3) Take reducing consumption as the primary goal and improving efficiency;
(4) Reasonably arrange and use funds and improve the utilization rate of funds;
(5) Strengthen financial management, strengthen cost control analysis, budget implementation and supervision of fund operation, establish an early warning mechanism for cost control, budget implementation and fund operation, reduce financial risks, find problems in time and make continuous improvement, so as to ensure the realization of financial indicators.
Special note: this budget aims to clarify the internal management control indicators of the company’s 2022 business plan, which does not represent the company’s profit forecast or the commitment to investors. Whether it can be realized depends on the macroeconomic environment, market conditions, industry development and other factors, and there is great uncertainty. Investors should pay special attention to it Aoyuan Beauty Valley Technology Co.Ltd(000615) April 30, 2002
